Learn more

HUNAN YUANPIN CELL BIOTECH CO LTD

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    68,858
About

HUNAN YUANPIN CELL BIOTECH CO LTD has a total of 24 patent applications. Its first patent ever was published in 2019. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NAT CENTER OF NEUROLOGY & PSYCHIATRY, HADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED and BAVARIAN NORDIC AS.

Patent filings in countries

World map showing HUNAN YUANPIN CELL BIOTECH CO LTDs patent filings in countries
# Country Total Patents
#1 China 24

Patent filings per year

Chart showing HUNAN YUANPIN CELL BIOTECH CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Cheng 10
#2 Zheng Chunbing 9
#3 Wang Jian 8
#4 Yi Ning 8
#5 Lyu Bo 8
#6 Li Chanyi 7
#7 Li Weilin 7
#8 Xue Zhigang 6
#9 Xue Jinfeng 6
#10 Qi Lingbin 6

Latest patents

Publication Filing date Title
CN112022877A Application of MSC (mesenchymal stem cell) in regulating and controlling gene expression of terminally differentiated cells of virus infected patients
CN112057474A Application of mesenchymal stem cells in regulating and controlling mononuclear cells of virus infection patient
CN112043725A Application of mesenchymal stem cells in improvement of human body oxidative stress state
CN111681768A Application of blood index in detecting severity of coronavirus infection patient
CN111568930A Application of MSC (mesenchymal stem cell) in adjusting number of NK (natural killer) cells
CN111518196A TCR enrichment clone type and acquisition method and application thereof
CN111574615A TCR enrichment clone type and acquisition method and application thereof
CN111568928A Application of MSC (mesenchymal stem cell) in regulating and controlling gene expression of effector CD8+ T cells
CN111518195A TCR enrichment clone type and acquisition method and application thereof
CN111557950A Application of MSC (mesenchymal stem cell) in regulating and controlling NK (natural killer) cell gene expression
CN111557951A Novel method for treating virus infection patient by mesenchymal stem cells
CN111514169A Application of MSC (Mobile switching center) in inhibiting virus replication
CN111568931A Application of MSC (mesenchymal stem cell) in regulating and controlling human body effect CD4+ T memory cell gene expression
CN111574613A TCR enrichment clone type and acquisition method and application thereof
CN111529551A Application of MSC (mesenchymal stem cell) in adjusting number of plasma cells
CN111574614A TCR enrichment clone type and acquisition method and application thereof
CN111467376A Application of MSC (Mobile switching center) in relieving influence of cytokine storm
CN111544452A Application of MSC (mesenchymal stem cell) in regulating number of CD4+ T cells
CN111568929A Application of MSC (mesenchymal stem cell) in regulating number of effector CD8+ T cells
CN111568927A Application of MSC (mesenchymal stem cell) in regulating number of memory B cells